SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-24-000113
Filing Date
2024-05-22
Accepted
2024-05-22 12:39:37
Documents
14
Period of Report
2024-05-22
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K MAY 22, 2024 pfe-20240522.htm   iXBRL 8-K 35731
  Complete submission text file 0000078003-24-000113.txt   200808

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20240522.xsd EX-101.SCH 2737
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20240522_def.xml EX-101.DEF 15360
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20240522_lab.xml EX-101.LAB 27449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20240522_pre.xml EX-101.PRE 16027
17 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20240522_htm.xml XML 4273
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 24972633
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)